Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and azd 6244

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with azd 6244 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hui, PP; Ma, JL; Wang, N; Wang, T; Wei, J	1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and azd 6244

Article	Year
The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244. Biochemical and biophysical research communications, 2015, Jan-16, Volume: 456, Issue:3 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosyltransferases; Humans; Morpholines; Pancreatic Neoplasms; Protein Kinase Inhibitors	2015

Article

Year

The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.

Biochemical and biophysical research communications, 2015, Jan-16, Volume: 456, Issue:3

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosyltransferases; Humans; Morpholines; Pancreatic Neoplasms; Protein Kinase Inhibitors

2015